Cline Christopher R. — SEC insider filings

SEC reporting owner CIK 1943192. 24 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2022-09-01 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Travere Therapeutics, Inc. (TVTX)CHIEF FINANCIAL OFFICER24—32 legs · 111,015 sh · $4,964,98423

Insider filings — Cline Christopher R.

FiledFormIssuerReported transactionsSource
2026-09-174Travere Therapeutics, Inc. (TVTX)Option exercise (M): 20,000 @ $17.44 · Sale (S): 27,473 @ $62.00 · Sale (S): 20,735 @ $62.61 · Sale (S): 1,900 @ $63.69 · Sale (S): 400 @ $65.31 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-09-034Travere Therapeutics, Inc. (TVTX)Sale (S): 642 @ $66.37EDGAR
2026-05-064Travere Therapeutics, Inc. (TVTX)Option exercise (M): 4,250 @ $0 · Sale (S): 2,181 @ $46.65 · Sale (S): 310 @ $43.95 · Grant/award (A): 8,500 (derivative) @ $0 · Option exercise (M): 4,250 (derivative) @ $0EDGAR
2026-04-154Travere Therapeutics, Inc. (TVTX)Grant/award (A): 14,000 @ $0 · Sale (S): 65 @ $28.85 · Sale (S): 9 @ $41.07 · Sale (S): 7,239 @ $41.93 · Sale (S): 1,014 @ $42.61EDGAR
2026-02-054Travere Therapeutics, Inc. (TVTX)Sale (S): 1,635 @ $32.14 · Sale (S): 110 @ $32.90EDGAR
2026-02-034Travere Therapeutics, Inc. (TVTX)Grant/award (A): 28,130 @ $0 · Sale (S): 7,242 @ $32.12 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2025-12-034Travere Therapeutics, Inc. (TVTX)Option exercise (M): 20,000 @ $16.23 · Sale (S): 20,000 @ $35.01 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2025-09-054Travere Therapeutics, Inc. (TVTX)Sale (S): 454 @ $18.20 · Sale (S): 119 @ $19.71EDGAR
2025-08-284Travere Therapeutics, Inc. (TVTX)Sale (S): 470 @ $17.31EDGAR
2025-05-054Travere Therapeutics, Inc. (TVTX)Option exercise (M): 4,920 · Sale (S): 1,784 @ $21.05 · Option exercise (M): 4,920 (derivative) @ $0EDGAR
2025-04-144Travere Therapeutics, Inc. (TVTX)Sale (S): 48 @ $13.14EDGAR
2025-02-044Travere Therapeutics, Inc. (TVTX)Grant/award (A): 21,500 @ $0 · Sale (S): 5,192 @ $20.12 · Grant/award (A): 58,000 (derivative) @ $0EDGAR
2025-01-234Travere Therapeutics, Inc. (TVTX)Sale (S): 865 @ $18.94EDGAR
2024-09-094Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,750 @ $0 · Sale (S): 2,490 @ $11.52EDGAR
2024-09-054Travere Therapeutics, Inc. (TVTX)Sale (S): 514 @ $9.51EDGAR
2024-04-124Travere Therapeutics, Inc. (TVTX)Sale (S): 54 @ $6.74EDGAR
2024-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 25,000 @ $0 · Sale (S): 3,818 @ $8.53 · Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-01-254Travere Therapeutics, Inc. (TVTX)Sale (S): 853 @ $9.07EDGAR
2023-09-054Travere Therapeutics, Inc. (TVTX)Sale (S): 457 @ $14.71EDGAR
2023-05-124Travere Therapeutics, Inc. (TVTX)Sale (S): 455 @ $16.59EDGAR
2023-04-134Travere Therapeutics, Inc. (TVTX)Sale (S): 47 @ $21.49EDGAR
2023-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 20,250 @ $0 · Sale (S): 1,588 @ $21.75 · Grant/award (A): 54,500 (derivative) @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2023-01-264Travere Therapeutics, Inc. (TVTX)Sale (S): 852 @ $21.90EDGAR
2022-09-014Travere Therapeutics, Inc. (TVTX)Grant/award (A): 5,000 @ $0 · Grant/award (A): 48,000 (derivative) @ $0 · Grant/award (A): 9,840 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1943192 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs